Zymeworks (ZYME) Tops Q4 EPS by 22c

Zymeworks (NYSE: ZYME) reported Q4 EPS of ($0.95), $0.22 better than the analyst estimate of ($1.17). Revenue for the quarter came in at $19.87 million versus the consensus estimate of $9.13 million.

For earnings history and earnings-related data on Zymeworks (ZYME) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
• BofA lists top 5 themes driving next $1tn in incremental semi sales